Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 12 pseudogene 1 (PEX12P1) is a genomic locus exhibiting high sequence similarity to the functional PEX12 gene but contains mutations that prevent it from encoding a functional protein. Like other pseudogenes, it may retain elements (such as microRNA binding sites) that can, in principle, regulate the expression of its parental gene through a competitive endogenous RNA mechanism, although this has not been specifically demonstrated for PEX12P1. Pseudogenes have increasingly been recognized as having regulatory roles at the RNA level in various biological processes and diseases but PEX12P1 lacks direct evidence of such activity or disease involvement currently[2][4][5]. There is no evidence that PEX12P1 acts as a receptor, enzyme, transporter, or canonical therapeutic target, nor is it associated with clinical drug interactions or safety concerns. Most scientific and clinical databases classify it unambiguously as a pseudogene, a non-protein coding genetic element[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 12 pseudogene 1 (PEX12P1).